Invesaro

Stocks Health care IMCC

NASDAQ · Health care

IM Cannabis Corp. (IMCC)

IM Cannabis Corp. reported revenue of CA$54.7M in fiscal 2025, up 1.3% from a year earlier. It posted a net loss of CA$11.3M. Operating cash flow minus capital spending left CA$4.7M of free cash flow in fiscal 2025. At December 31, 2025 it held CA$2.7M in cash against CA$15.3M of debt. Its latest periodic report to the SEC is the annual report (foreign issuer) (20-F) filed on March 30, 2026.

Watch IMCC in 60 seconds
Price
$2.48
-12.68% on the day · September 28, 2026
52-week range $1.55 to $77.10
Market cap
$15.4M
Revenue (FY2025)
CA$54.7M
+1.3% year on year
Net margin
-20.7%

What IM Cannabis Corp. does

IM Cannabis Corp. is registered with the SEC under industry code SIC 2833 (Medicinal Chemicals & Botanical Products). Its shares trade on NASDAQ under the ticker IMCC.

Revenue and profit by year

Revenue
FY20: CA$9.1M CA$9.1M FY20FY20: CA$15.9M CA$15.9M FY20FY21: CA$34.1M CA$34.1M FY21FY22: CA$54.3M CA$54.3M FY22FY23: CA$48.8M CA$48.8M FY23FY24: CA$54M CA$54M FY24FY25: CA$54.7M CA$54.7M FY25
Net income
FY20: -CA$7.3M -CA$7.3M FY20FY20: -CA$28.7M -CA$28.7M FY20FY21: -CA$17.8M -CA$17.8M FY21FY22: -CA$188.9M -CA$188.9M FY22FY23: -CA$9.5M -CA$9.5M FY23FY24: -CA$10.6M -CA$10.6M FY24FY25: -CA$11.3M -CA$11.3M FY25

Fiscal years as reported in annual reports. Amounts in CAD.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2025CA$54.7M-CA$11.6M-CA$11.3Mn/aCA$4.7M
2024CA$54M-CA$10.2M-CA$10.6M-CA$4.51-CA$1.2M
2023CA$48.8M-CA$12.8M-CA$9.5M-CA$4.45-CA$8.7M
2022CA$54.3M-CA$30.8M-CA$188.9M-CA$161.88-CA$14.2M
2021CA$34.1M-CA$23M-CA$17.8M-CA$40.20-CA$39M
2020CA$15.9M-CA$8.2M-CA$28.7M-CA$11.40-CA$10.5M

Full financial statements: income, balance sheet and cash flow

Where IMCC ranks in Health care

Revenue growth+1.3%
#391 of 529 in Health care · Bottom 26%
Net margin-20.7%
#326 of 541 in Health care · Bottom 40%
Free cash flow margin8.6%
#145 of 488 in Health care · Top 30%

Latest fiscal year of every company in the sector with the figure reported. Revenue is ranked among companies reporting in US dollars; growth and margins among companies with at least 10 million of revenue. Health care

Latest SEC filings

What IM Cannabis Corp. has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. September 25, 2026
    Foreign issuer update 6-K
  2. September 24, 2026
    Securities offering prospectus 424B5
  3. September 24, 2026
    Foreign issuer update 6-K
  4. September 23, 2026
    Foreign issuer update 6-K
  5. September 23, 2026
    Foreign issuer update 6-K
  6. September 2, 2026
    Foreign issuer update 6-K
  7. August 27, 2026
    Foreign issuer update 6-K
  8. August 18, 2026
    Foreign issuer update 6-K
  9. August 17, 2026
    Foreign issuer update 6-K
  10. August 13, 2026
    Foreign issuer update 6-K

All filings on SEC EDGAR

Questions about IMCC

What does IM Cannabis Corp. do?

IM Cannabis Corp. is registered with the SEC under industry code SIC 2833 (Medicinal Chemicals & Botanical Products). Its shares trade on NASDAQ under the ticker IMCC.

Is IM Cannabis Corp. profitable?

No. In fiscal 2025 it reported a net loss of CA$11.3M on revenue of CA$54.7M.

How much revenue does IM Cannabis Corp. make?

In fiscal 2025 IM Cannabis Corp. reported revenue of CA$54.7M. That is 1.3% more than a year earlier.

When did IM Cannabis Corp. last report?

Its most recent periodic report is the annual report (foreign issuer) (20-F) filed on March 30, 2026. It covers the period to December 31, 2025. Its newest filing of any kind is the foreign issuer update from September 25, 2026.

Similar companies

CURLF
Curaleaf Holdings, Inc.
TRLV
Trulieve Cannabis Corp.
SNDL
SNDL Inc.
USNA
Usana Health Sciences Inc
TLRY
Tilray Brands, Inc.
CRLBF
Cresco Labs Inc.

Compare IMCC with

Compare IMCC with any company

Follow IMCC

Get an email when IM Cannabis Corp. files with the SEC: results, executive changes, material agreements and annual reports.

Follow IMCC: get an email when it files

Where the numbers come from

Financial figures are the values IM Cannabis Corp. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.